MedPath

A study to evaluate the postprandial, short term effects of two baby nutrition products in adult, male volunteers

Completed
Conditions
Increased triglyceride concentrations
10013317
Registration Number
NL-OMON40343
Lead Sponsor
utricia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

- Healthy, adult, male, Caucasian, Dutch-speaking subjects
- Non-smokers
- Lactose- and milk-tolerant
- Age 18-25 yr
- Body Mass Index (BMI) of 20-25 kg/m2
- Girth width <100 cm
- Stable body weight (weight gain or loss < 2 kg in the past three months)
- Willing to give up being a blood donor (or having donated blood) from 8 weeks before the start of the study, during the study, and 4 weeks after the study (i.e. after the follow-up phone call)
- Written informed consent

Exclusion Criteria

- Top sports men or athletes with a daily strenuous training program (>2 hr)
- Known diseases or malfunctions e.g. fat malabsorption, gastrointestinal malformations, haemophilia, hepatitis B, human immunodeficiency virus (HIV), high blood-pressure, hyperlipidaemia or diabetes
- Current illnesses which could interfere with the study (e.g. prolonged severe diarrhoea, regurgitation, severe flu): to be determined on judgement of the investigator
- Medication use (except for paracetamol) or a medically prescribed diet
- More than 21 alcoholic consumptions per week
- Use of vitamin supplements, fish oil capsules or products rich in plant stanol or sterol esters during the study and 2 weeks in advance of study start
- Any current participation, or participation within 8 weeks before study start, in any other study involving investigational or marketed products
- Investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements and instructions

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Plasma triglyceride concentrations</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Concentrations of free fatty acids, lipoproteins, glucose, insuline, amino<br /><br>acids and satiety hormones. </p><br>
© Copyright 2025. All Rights Reserved by MedPath